07Jan
DEAL WATCH: End-of-Year Biosimilar Agreements
Following the string of biosimilar agreements announced in early November, a number of additional transactions were announced in early December, bringing 2019 to a roaring close with global biosimilars deals. On December 1, 2019, Luye Pharma Group...
By:
Goodwin
Related
The COVID-19 pandemic has had far-reaching effects to date, including economic uncertainty and wides...
Read More >
The statute of limitations of Title VII of the Civil Rights Act of 1964 cannot be contractually shor...
Read More >
SB 35 was one of the most prominent bills to come out of a package of housing-related laws enacted b...
Read More >
Last month, the United States Court of Appeals for the Ninth Circuit certified two questions of stat...
Read More >
Due to a recent court decision, metal/nonmetal mine operators are again facing the possibility of ha...
Read More >
On December 16, 2019, the IRS issued proposed regulations under Section 162(m) of the Internal Reven...
Read More >